2025-2030 年全球组织移植市场预测

组织移植市场预计将从 2025 年的 100.16 亿美元成长到 2030 年的 143.91 亿美元，复合年增长率为 7.52%。

由于慢性病的盛行率不断上升、健康意识的不断增强以及技术的进步，组织移植市场正在经历显着增长。组织移植（移植物）是指将组织从一个部位移植到同一个体或不同个体的另一个部位，以恢復因糖尿病、癌症、心血管疾病、阿兹海默症症等疾病而严重受损的器官或组织的功能。由于这些慢性疾病通常会导致不可逆的组织损伤，因此移植已成为重获健康生活的重要解决方案。

市场驱动因素

• 慢性疾病和伤害案例增加

慢性病的激增增加了永久性组织损伤的风险，从而刺激了组织移植的需求。常见的手术包括皮肤、角膜、骨骼、心臟瓣膜、肌腱、神经、静脉等移植。烧烫伤和损伤病例的增加进一步推动了市场的发展。例如，欧洲道路安全观察站2023年的研究报告显示，西班牙发生了102,362起伤害事故，凸显了组织移植治疗此类损伤的必要性。

• 皮肤移植

由于烧烫伤、酸损伤、皮肤癌、糖尿病和其他疾病的发生率不断上升，皮肤移植领域预计将占据重要的市场占有率。皮肤移植透过从患者身体的某部位切取小块皮肤，并将其移植到受损区域，可以有效地治疗大面积损伤。全球范围内这些疾病的发病率上升推动了该领域的成长。

• 同种异体移植段的生长

异基因移植领域涉及不同物种个体之间的组织和器官移植，预计将以显着的复合年增长率成长。异基因移植产品改善患者预后以及市场参与企业的策略性扩张是关键驱动因素。虽然目前尚无2023年后的案例，但对扩大异体移植产品供应的关注将持续支持该领域的成长。

• 技术进步

移植技术的进步预计将透过改善治疗效果和提高可及性来刺激市场扩张。这些创新为改善治疗效果和更广泛地应用组织移植创造了机会。

市场挑战

儘管组织移植市场潜力巨大，但它仍面临移植排斥等挑战，这成为其广泛应用的主要障碍。此外，部分地区对组织移植的认知度较低，也限制了市场扩张。

地理视角

北美预计将主导组织移植市场，这得益于其先进的医疗基础设施和主要行业参与者的参与。欧洲是第二大市场，得益于高额的研发投入和庞大的病患群。预计这些因素将在预测期内维持该地区的成长。

随着慢性病盛行率上升、技术进步以及损伤相关需求的增加，组织移植市场预计将持续成长。然而，要充分发挥市场潜力，需要解决移植排斥反应和认知差距等挑战。在强大的医疗保健体系和持续的技术创新的支持下，北美和欧洲预计将引领这一趋势。

本报告的主要优点

• 深刻分析：获得涵盖主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他细分市场。
• 竞争格局：了解全球主要企业所采用的策略策略，并了解正确策略带来的潜在市场渗透。
• 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响市场的未来发展。
• 可行的建议：利用洞察力进行策略决策，在动态环境中开闢新的业务流和收益。
• 适用范围广：对于新兴企业、科学研究机构、顾问公司、中小企业、大型企业都有利且划算。

它有什么用途？

产业和市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

• 2022 年至 2024 年的历史数据和 2025 年至 2030 年的预测数据
• 成长机会、挑战、供应链前景、法律规范与趋势分析
• 竞争定位、策略和市场占有率分析
• 各细分市场和地区（包括国家）的收益成长和预测分析

公司简介

目录

第一章执行摘要

第二章市场概述

• 市场概览
• 市场定义
• 研究范围
• 市场区隔

第三章 商业景气

• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策法规
• 策略建议

第四章 技术展望

5. 全球组织移植市场（依组织类型）

• 介绍
• 角膜
• 皮肤
• 骨髓
• 其他的

6. 全球组织移植市场（依移植类型）

• 介绍
• 自体移植
• 同种异体移植
• 异种移植

7. 全球组织移植市场（依最终使用者）

• 介绍
• 医院
• 手术中心
• 其他的

8. 全球组织移植市场（按地区）

• 介绍
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他的
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
  • 其他的

第九章竞争格局及分析

• 主要企业和策略分析
• 市场占有率分析
• 合併、收购、协议和合作
• 竞争仪錶板

第十章 公司简介

• Pinnacle Transplant Technologies, Inc.
• CryoLife, Inc（Artivion Inc）
• RTI Surgical Holdings, Inc.
• CBR Systems, Inc.
• Zimmer Biomet
• XVIVO
• Arthrex, Inc.
• Stryker Corporation
• Medtronic PLC

第十一章 附录

• 货币
• 先决条件
• 基准年和预测年时间表
• 相关人员的主要利益
• 调查方法
• 简称

The global tissue transplant market is expected to grow from USD 10.016 billion in 2025 to USD 14.391 billion in 2030, at a CAGR of 7.52%.

The global tissue transplant market is experiencing significant growth driven by the increasing prevalence of chronic diseases, rising health awareness, and technological advancements. Tissue transplants, or grafts, involve transferring tissue from one location to another within the same or different individuals to restore functionality in cases of severe organ or tissue damage caused by conditions such as diabetes, cancer, cardiovascular disease, renal disease, and Alzheimer's disease. These chronic conditions often lead to irreversible tissue damage, making transplantation a critical solution for restoring a healthy life.

Market Drivers

• Rising Chronic Diseases and Injury Cases

The surge in chronic diseases has heightened the risk of permanent tissue damage, increasing the demand for tissue transplants. Commonly performed procedures include transplants of skin, cornea, bones, heart valves, tendons, nerves, and veins. The market is further propelled by a growing number of burn and injury cases. For instance, a 2023 European Road Safety Observatory study reported 102,362 injury accidents in Spain, underscoring the need for tissue transplantation to address such injuries.

• Skin Transplantation

The skin transplant segment is anticipated to hold a significant market share due to the rising incidence of burns, acid injuries, and conditions like skin cancer and diabetes. Skin grafting involves harvesting a small patch of skin from one part of a patient's body and transplanting it to the damaged area, effectively treating extensive injuries. This segment's growth is driven by the increasing prevalence of these conditions globally.

• Allograft Segment Growth

The allograft segment, involving the transplantation of tissue or organs between non-identical individuals of the same species, is projected to grow at a significant compound annual growth rate (CAGR). Improved patient outcomes from allograft products and strategic expansions by market players are key drivers. While no specific post-2023 examples are available, the focus on expanding allograft product offerings continues to support this segment's growth.

• Technological Advancements

Advancements in transplant technologies are expected to fuel market expansion by improving procedure outcomes and accessibility. These innovations create opportunities for enhanced treatment efficacy and broader adoption of tissue transplantation.

Market Challenges

Despite its growth potential, the tissue transplant market faces challenges, including transplant rejection, which remains a significant barrier to widespread adoption. Additionally, limited awareness about tissue transplantation in certain regions restricts market expansion.

Geographical Outlook

North America is expected to dominate the tissue transplant market due to its advanced healthcare infrastructure and the presence of key industry players. Europe follows as the second-largest market, driven by substantial investments in research and development and a large patient population. These factors are anticipated to sustain regional growth over the forecast period.

The tissue transplant market is poised for growth, driven by rising chronic disease prevalence, technological advancements, and increasing injury-related demand. However, challenges like transplant rejection and awareness gaps must be addressed to fully realize the market's potential. North America and Europe are expected to lead, supported by robust healthcare systems and ongoing innovation.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries

Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Global Tissue Transplant Market Segmentation

By Tissue Type

• Cornea
• Skin
• Bone Marrow
• Others

By Graft Type

• Autograft
• Allograft
• Xenograft

By End-User

• Hospitals
• Surgical Centers
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Italy
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• Japan
• India
• South Korea
• Indonesia
• Thailand
• Taiwan
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL TISSUE TRANSPLANT MARKET BY TISSUE TYPE

• 5.1. Introduction
• 5.2. Cornea
• 5.3. Skin
• 5.4. Bone Marrow
• 5.5. Others

6. GLOBAL TISSUE TRANSPLANT MARKET BY GRAFT TYPE

• 6.1. Introduction
• 6.2. Autograft
• 6.3. Allograft
• 6.4. Xenograft

7. GLOBAL TISSUE TRANSPLANT MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Surgical Centers
• 7.4. Others

8. GLOBAL TISSUE TRANSPLANT MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Pinnacle Transplant Technologies, Inc.
• 10.2. CryoLife, Inc (Artivion Inc)
• 10.3. RTI Surgical Holdings, Inc.
• 10.4. CBR Systems, Inc.
• 10.5. Zimmer Biomet
• 10.6. XVIVO
• 10.7. Arthrex, Inc.
• 10.8. Stryker Corporation
• 10.9. Medtronic PLC

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key benefits for the stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations